New dry eye treatment for people with Sjögren's syndrome
Part of Eyes & vision, Immune system & allergy clinical trials.
This study tests a new treatment for dry eye disease caused by Sjögren's syndrome. It may help people who still have dry eye symptoms even when using artificial tears.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You were diagnosed with dry eye due to Sjögren's syndrome in the last 2 years
- You have used or wanted to use artificial tears for dry eye in the past 2 months
- You have not had any eye surgery in the last 6 months
- You are not currently wearing contact lenses (or willing to stop for the study)
- You are not using certain steroid eye drops or a steroid nasal spray
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an eye drop version of infliximab, a medication that reduces inflammation, can help people with Sjögren's syndrome who have severe dry eye. You would keep taking your current medications and add these drops to see if they improve symptoms and eye surface damage.
This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.
This trial tests whether a dietary supplement called TRYPTYR can improve dry eye symptoms. You may qualify if you have moderate dry eye with certain signs, like short tear breakup time and staining on your eye surface.
This study tests a new eye drop called TRYPTYR to see if it can improve quality of life and daily tasks for people with dry eye disease who are unhappy with their current treatment, Restasis. Participants will stop using Restasis and switch to TRYPTYR for about 4 weeks.
This study tests a new dry eye drop called TRYPTYR for people who have been using Restasis but are not satisfied with it. If you qualify, you would stop Restasis and try TRYPTYR to see if it works better for your symptoms.
This study tests a new eye drop called Acoltremon to see if it can relieve symptoms of moderate-to-severe dry eye disease. It may be a good option if you have had dry eye for at least 6 months and use artificial tears.
Hear when a new Sjogren Syndrome With Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.